Lorena E. Brown

Department of Microbiology and Immunology, University of Melbourne

Research Area

Biography

Lorena E. Brown has not added Biography.
If you are Lorena E. Brown and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 38	2011

Other Publications

Article	Year
Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus. Journal of virology\| PubMed ID: 11932386	2002
Identification of antigenically active tryptic fragments of apical membrane antigen-1 (AMA1) of Plasmodium chabaudi malaria: strategies for assembly of immunologically active peptides. Vaccine\| PubMed ID: 12297393	2002
Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 12391202	2002
Immune responses in hepatitis C virus infection: the role of dendritic cells. Immunology and cell biology\| PubMed ID: 12534948	2003
Maturation of dendritic cells with lipopeptides that represent vaccine candidates for hepatitis C virus. Immunology and cell biology\| PubMed ID: 12534949	2003
Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 12601154	2003
Responses against complex antigens in various models of CD4 T-cell deficiency: surprises from an anti-CD4 antibody transgenic mouse. Immunologic research\| PubMed ID: 15258307	2004
A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 15489266	2004
ISCOM-based vaccines: the second decade. Immunology and cell biology\| PubMed ID: 15748208	2005
Lipid-based self-adjuvanting vaccines. Current drug delivery\| PubMed ID: 16305441	2005
Targeting CD45RB alters T cell migration and delays viral clearance. International immunology\| PubMed ID: 16361310	2006
Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza. European journal of immunology\| PubMed ID: 16435281	2006
Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines. International immunology\| PubMed ID: 17077175	2006
Pandemic vaccines: promises and pitfalls. The Medical journal of Australia\| PubMed ID: 17115955	2006
Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 18292565	2008
A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection. Vaccine\| PubMed ID: 18455278	2008
Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections. Vaccine\| PubMed ID: 18725260	2008
Selected Toll-like receptor ligands and viruses promote helper-independent cytotoxic T cell priming by upregulating CD40L on dendritic cells. Immunity\| PubMed ID: 19200758	2009
Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes. Immunology and cell biology\| PubMed ID: 19308073	2009
Single dose intranasal immunization with ISCOMATRIX vaccines to elicit antibody-mediated clearance of influenza virus requires delivery to the lower respiratory tract. Vaccine\| PubMed ID: 19368789	2009
Lipopeptide vaccines illustrate the potential role of subtype-crossreactive T cells in the control of highly virulent influenza. Influenza and other respiratory viruses\| PubMed ID: 19627375	2009
Q&A: What have we found out about the influenza A (H1N1) 2009 pandemic virus? Journal of biology\| PubMed ID: 19769786	2009
Influenza A virus facilitates Streptococcus pneumoniae transmission and disease. FASEB journal : official publication of the Federation of American Societies for Experimental Biology\| PubMed ID: 20097876	2010
A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody. Immunology and cell biology\| PubMed ID: 20177411	2010
Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model. PloS one\| PubMed ID: 20422002	2010
Role of CD8(+) T-cell immunity in influenza infection: potential use in future vaccine development. Expert review of respiratory medicine\| PubMed ID: 20477341	2009
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals. Journal of hepatology\| PubMed ID: 20667615	2010
The role of adjuvants in vaccines for seasonal and pandemic influenza. Vaccine\| PubMed ID: 20849874	2010
Prevention and treatment of influenza with hyperimmune bovine colostrum antibody. PloS one\| PubMed ID: 21049034	2010
Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 21371510	2011
The role of neutrophils during mild and severe influenza virus infections of mice. PloS one\| PubMed ID: 21423798	2011
The linear range for accurately quantifying antigen-specific T-cell frequencies by tetramer staining during natural immune responses. European journal of immunology\| PubMed ID: 21469136	2011
Rapid kinetics to peak serum antibodies is achieved following influenza vaccination by dry-coated densely packed microprojections to skin. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 22063004	2011
Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 22306334	2012